NXTG.TA TLV
Nextage Therapeutics Ltd
1W: +8.4%
1M: +20.5%
3M: -11.0%
YTD: -12.0%
1Y: -62.6%
3Y: -58.3%
5Y: -93.0%
₪38.70 ($0.13)
-0.10 (-0.26%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$795K
+64.9% ▲
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$795K
+64.9% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$404K
+37.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$7M | -$8M | -$6M | -$4M | -$3M |
| Depreciation & Amort. | $96K | $190K | $57K | $128K | $100K |
| Stock-Based Comp. | $3M | $2M | $465K | $90K | $1K |
| Change in Working Capital | -$3M | $973K | -$516K | $2M | $3M |
| Other Non-Cash Items | -$929K | -$14K | $15K | $5K | $5K |
| Operating Cash Flow | -$7M | -$2M | -$6M | -$2M | -$795K |
| — Investing Activities — | |||||
| Capital Expenditures | -$10K | $0 | -$4K | $0 | $0 |
| Acquisitions (Net) | $8M | $0 | $0 | $0 | $0 |
| Investment Purchases | -$16K | -$64K | $0 | $0 | $0 |
| Investment Sales | -$8M | $0 | $21K | $3K | $0 |
| Other Investing | $149K | -$5M | $0 | $0 | -$178K |
| Investing Cash Flow | $149K | -$5M | $17K | $3K | -$178K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$2M | $760K | $6K | $410K | -$73K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$66K | -$97K | -$57K | -$94K | -$27K |
| Financing Cash Flow | $395K | $5M | $3M | $1M | $539K |
| Net Change in Cash | $668K | -$2M | -$2M | -$647K | -$404K |
| Cash End of Period | $2M | -$664K | $1M | $404K | $0 |
| Free Cash Flow | -$7M | -$2M | -$6M | -$2M | -$795K |